Admission Date:  [**2110-5-9**]              Discharge Date:   [**2110-5-17**]   Service: MEDICINE  Allergies: Codeine  Attending:[**First Name3 (LF) 1711**] Chief Complaint: Transfer to CCU s/p pericardiocentesis with drain placement.
She is getting treated with Tarceva for her stage III B tumor which was started 5 weeks ago.
She was subsequently brought to the cath lab where she had a pericardial tap and window.
Approx 850cc of serosanguanous fluid was removed and sent to the lab.
She had immediate improvement of her BP and a pericardial drain was left in place.
Locally advanced non-small cell lung cancer diagnosed [**2-/2110**], status post 7 cycles of Navelbine (last [**2110-11-26**]).
Slight progression of a right paratracheal lymph node was noted on CT [**2110-12-8**], as well as a node anterior to the SVC.
History of DVT and PE in [**3-/2110**], status post IVC filter placement.
Peripheral neuropathy secondary to Navelbine treatment 5.
Pericardial drain in place LUNGS: CTA, BS BL, No W/R/C ABD: Soft, NT, ND.
Pericardial Fluid Exam [**5-9**]: POSITIVE FOR MALIGNANT CELLS consistent with metastatic   non-small cell carcinoma of the lung (patient's slide of lung cancer [S06-[**Numeric Identifier 96473**]] reviewed).
Successful balloon pericardiotomy.
# Pericardial Effusion:  Pt came to CCU s/p Pericardiocentesis with window and drain in place.
She had a slight temo on [**5-10**] and Levofloxacin was commenced and cultures sent.
The drain was removed.
# Pleural Effusions: She was breathless at times with effusions on CXR and CTA.
Onc saw her and recommended thoracentesis for pericardial effusions which she underwent on [**5-13**].
The fluid revealed  rare atypical cells of uncertain significance, Mesothelial cells, scattered lymphocytes and neutrophils.
# Lung CA:  As outlined above, this is (T4, N3 disease which is consistent with stage III B) treated with Tarceva for now.
Heparin gtt was continued given past history of DVT and hypercoagulable state given tumor and eventually switched to Lovenox.
# CODE: FULL CODE confirmed with pt on arrival to CCU  Medications on Admission: Tarceva 150mg daily Lovenox 80mg daily Protonix 40mg daily   Discharge Medications: 1.
Tarceva 150 mg Tablet Sig: One (1) Tablet PO qD ().
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Enoxaparin 60 mg/0.6 mL Syringe Sig: One (1)  Subcutaneous [**Hospital1 **] (2 times a day).
Metoprolol Succinate 25 mg Tablet Sustained Release 24HR Sig: Three (3) Tablet Sustained Release 24HR PO DAILY (Daily).
Disp:*90 Tablet Sustained Release 24HR(s)* Refills:*2* 5.
Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical  TID (3 times a day) as needed.
Discharge Instructions: Please take all medications as prescribed and keep all follow-up appointments.
You will need to leave the foley catheter in place until you follow-up with urology.
Followup Instructions: You should follow-up with your oncologist as follows: Provider: [**First Name8 (NamePattern2) 251**] [**Name11 (NameIs) **], MD Phone:[**0-0-**] Date/Time:[**2110-5-20**] 9:30 [**Hospital Ward Name 23**] 9, [**Hospital Ward Name **] [**Hospital1 18**]  You should follow-up in the interventional pulmonary as follows: Dr. [**First Name (STitle) **] and Dr. [**Last Name (STitle) **](Interventional Pulmonary)  Deaconness 207 (enter through [**Hospital Ward Name 121**] enterance- big door on left before pay phone) [**Hospital Ward Name **], [**Hospital1 18**].
